| HOME >> MEDICINE >> TECHNOLOGY |
RECONCILIATION OF GAAP EPS AND NET (LOSS) INCOME TO NON-GAAP ADJUSTED EPS, NET INCOME AND EBITDA
(Unaudited)
(In thousands, except earnings per share)Three Months EndedThree Months EndedSeptember 25, 2010September 26, 2009 (1)EARNINGS PER SHAREGAAP (loss) earnings per share- Diluted
$(0.53)$0.09
(1)Adjustments to net (loss) income (as detailed below)
0.830.19Non-GAAP adjusted earnings per share- Diluted
$0.30
(2)$0.28
(2)NET (LOSS) INCOMEGAAP net (loss) income
$(136,974)$24,568
(1)Adjustments:Amortization of intangible assets
55,00652,094Non-cash interest expense relating to convertible debt
18,71217,334Impairment of goodwill
76,723-Impairment of intangible assets
143,467-Acquired in-process research and development
2,000-Acquisition-related costs
1,430-Litigation-related settlement benefit
(1,097)-Fair value write-up of acquired inventory sold
73283Divestiture, closing and restructuring costs
8852,002Income tax effect of reconciling items
(81,580)
(3)(23,118)
(4)Non-GAAP adjusted net income
$79,304$72,963EBITDANon-GAAP adjusted net income
$79,304$72,963Interest expense, net, not adjusted above
10,24615,752Provision for income taxes
45,96542,000Depreciation expense
17,43718,539Adjusted EBITDA
$152,952$149,254EXPLANATORY NOTES:(1) Adjusted for the retrospective adoption of ASC 470-20, "Accounting for Convertible Debt Instruments That May be Settled in Cash Upon Conversion," in accordance with GAAP.(2) Non-GAAP adjusted earnings per share was calculated based on 262,32
'/>"/>
| SOURCE Hologic, Inc. Copyright©2010 PR Newswire. All rights reserved |